3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
79
Neoplasms
9
Carcinoma, Intraductal, Noninfiltrating
5
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Breast Carcinoma In Situ
3
Arthralgia
3
Triple Negative Breast Neoplasms
2
Sexual Dysfunction, Physiological
1
Seizures
1
Recurrence
1
Pain
1
Osteoporosis
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Lethal Congenital Contracture Syndrome 2
1
Joint Diseases
1
Invasive Breast Cancer
1
Hypogonadism
1
Granulosa Cell Ovarian Cancer
1
Fractures, Bone
1
Erectile Dysfunction
1
Epilepsy
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Metastatic
1
Advanced Metastatic Breast Cancer
1
Advanced Breast Carcinoma
1
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
pembrolizumab
3
napabucasin
3
Paclitaxel
3
Irinotecan
3
selpercatinib
2
pralsetinib
2
patritumab
2
Standard of Care
2
Pemetrexed
2
Nivolumab
2
Fluorouracil
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Ascorbic Acid
2
Albumin-Bound Paclitaxel
2
valrubicin
1
sotorasib
1
ribociclib
1
relatlimab
1
pamiparib
1
osimertinib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Site
×
Anastrozole
×
Clear all
No trials found.